George Tziras

George Tziras
George Tziras

CEO

Chief Executive Officer

George initially joined Small Pharma in 2015 as a director before being appointed to the role of Chief Business Officer and director of the Company in 2021. He was appointed as CEO in July 2022.

George has over 15 years of experience in investment banking and international capital markets having worked at a number of global financial institutions including Goldman Sachs, Credit Suisse, Nomura, Lehman Brothers and CIBC. His experience spans a broad range of transactions including debt and equity financings; mergers, disposals and acquisitions; private equity buyouts and debt restructurings. He has also worked across a number of industries including healthcare.

George holds a BA from the University of Oxford and a MA from the Johns Hopkins School of Advanced International Studies. 

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

Get Small Pharma
Investor Updates

    Investor Deck

    Follow us: